Key Points

Scientists at BRIC-RGCB have created groundbreaking mirror-image nanopores that could revolutionize early disease detection. These synthetic molecular channels can selectively identify and filter molecules with remarkable precision. The research demonstrates potential applications in cancer diagnostics, personalized medicine, and treating neurodegenerative conditions. This innovative approach combines chemistry, nanotechnology, and medical research to open new frontiers in healthcare.

Key Points: BRIC-RGCB's Mirror Nanopores Breakthrough in Disease Detection

  • Synthetic peptide nanopores can detect molecular changes with unprecedented precision
  • Mirror-image structures show enhanced stability for medical diagnostics
  • Potential to identify early signs of cancer and neurodegenerative diseases
  • Collaborative research involving multiple Indian scientific institutions
2 min read

Mirror, mirror in lab: BRIC-RGCB scientists build tiny nanopores to spot diseases early

Scientists develop revolutionary mirror-image nanopores that can detect diseases early and potentially target cancer cells with precision.

"These nanopores are like highly selective gates - Dr. K.R. Mahendran"

Thiruvananthapuram, Oct 3

Imagine a microscopic tunnel that can tell whether you might be developing cancer -- well, scientists at BRIC-RGCB, Thiruvananthapuram, are turning that imagination into reality.

In a breakthrough study, researchers have created mirror-image nanopores, tiny protein-like channels designed to act like a reflection of natural molecules.

Led by Dr. K.R.Mahendran, the team built these synthetic structures, named DpPorA, from special peptides that are flipped versions of natural proteins.

Computer simulations confirmed that the mirror-image pores are structurally opposite to their natural counterparts -- and surprisingly, this "mirror trick" makes them more stable and selective.

Their findings were recently published in Nature Communications.

"These nanopores are like highly selective gates," explained Dr. Mahendran.

"We can tune them to let certain molecules pass while blocking others. That means we can detect everything from tiny sugar rings to full-size proteins, which opens the door to early detection of diseases and even personalised diagnostics."

But the innovation doesn't stop there. Lab tests revealed that these mirror molecules can target and damage cancer cells while leaving healthy cells unharmed -- hinting at future therapies that could fight cancer safely.

Prof. Chandrabhas Narayana, RGCB Director, hailed the discovery as a game-changer.

"It has enormous potential -- not only in cancer, but also in healing wounds, repairing muscles, and boosting immune function. It could even help tackle neurodegenerative conditions like Alzheimer's and Parkinson's," he said.

The work was a collaborative effort, involving CSIR-NIIST, Thiruvananthapuram, Constructor University, Germany, and the Centre for Human Genetics, Bengaluru.

Funding came from top Indian science bodies, including the Department of Biotechnology, Department of Science and Technology, ICMR, and CSIR.

By combining chemistry, nanotechnology, and cancer biology, this research has created a powerful new tool that could revolutionise medical diagnostics.

These tiny mirror-image pores may one day help detect diseases early, safely, and precisely, transforming the way doctors diagnose and treat illnesses.

- IANS

Share this article:

Reader Comments

R
Rohit P
Great to see Indian research getting published in Nature Communications! But I hope this technology becomes affordable for the common man. Often such breakthroughs remain too expensive for regular hospitals in India.
A
Arjun K
Thiruvananthapuram becoming a biotech hub! So proud of our Kerala scientists. The fact that it can target cancer cells without harming healthy ones is revolutionary. Hope this reaches patients soon! 🙏
S
Sarah B
As someone who lost a family member to cancer, this gives me hope. The potential applications for Alzheimer's and Parkinson's are equally exciting. When can we expect clinical trials?
V
Vikram M
Excellent collaboration between Indian and German institutes! This shows how global partnerships can accelerate medical research. The mirror-image concept is brilliant - simple yet powerful.
M
Michael C
The funding from DBT, DST, ICMR, and CSIR shows our government is investing in the right areas. More such projects should be supported to make India a global leader in medical technology.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50